Elevance Health Inc. (ELV) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Elevance Health Inc. (ELV) Healthcare & Pipeline Overview

Elevance Health Inc. provides health benefits and related services to approximately 118 million people, offering a diverse portfolio of medical, digital, and pharmacy solutions. Formerly known as Anthem, the company focuses on connecting consumers with comprehensive care across the healthcare journey, positioning it as a major player in the managed healthcare sector.

What Is the Investment Thesis for ELV?

The company's focus on digital health and integrated care models positions it well to capitalize on evolving healthcare trends. With a P/E ratio of 18.51 and a dividend yield of 1.81%, Elevance Health offers a blend of value and income. Key growth catalysts include expanding its digital health offerings and increasing penetration in government-sponsored programs. Potential risks include regulatory changes and increasing competition in the health benefits market. The company's ability to maintain its gross margin of 23.2% and drive further efficiencies will be crucial for sustained profitability.

Based on FMP financials and quantitative analysis

ELV Key Highlights

Elevance Health serves approximately 118 million people through its diverse portfolio of health solutions.

• The company's P/E ratio stands at 18.51, indicating a reasonable valuation relative to earnings.
• Elevance Health's gross margin is 23.2%, reflecting its ability to manage healthcare costs and generate revenue effectively.
• The company offers a dividend yield of 1.81%, providing investors with a steady income stream.
• Elevance Health's beta of 0.50 suggests lower volatility compared to the broader market.

Who Are ELV's Competitors?

ELV is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ELV's Key Strengths?

Large membership base of approximately 118 million people.

• Diversified portfolio of medical, digital, pharmacy, and behavioral health solutions.
• Strong brand recognition and reputation in the health insurance industry.
• Experienced management team with a proven track record.

What Are ELV's Weaknesses?

Exposure to regulatory changes and healthcare reform.

• Dependence on government-sponsored programs.
• Competition from other large health insurers and managed care organizations.
• Potential for rising healthcare costs to impact profitability.

What Could Drive ELV Stock Higher?

Expansion of digital health platforms to improve member engagement and access to care.

• Strategic partnerships with healthcare providers to enhance value-based care models.
• Potential regulatory changes that could expand access to government-sponsored healthcare programs.
• Continued focus on data analytics to improve care management and personalize member experiences.

What Are the Key Risks for ELV?

Increasing competition from other health insurers and managed care organizations.

• Rising healthcare costs and potential for medical loss ratio to exceed expectations.
• Regulatory changes and healthcare reform that could impact the company's business model.
• Cybersecurity threats and data breaches that could compromise member information.

What Are the Growth Opportunities for ELV?

• Growth opportunity 1: Expanding Digital Health Offerings: Elevance Health can further expand its digital health offerings, including telehealth, remote monitoring, and digital therapeutics. By leveraging technology, Elevance Health can improve access to care, enhance patient engagement, and reduce healthcare costs. This includes personalized wellness programs and virtual care solutions, creating a competitive advantage.
• Growth opportunity 2: Increasing Penetration in Government-Sponsored Programs: Elevance Health can increase its penetration in government-sponsored programs such as Medicare and Medicaid. These programs represent a large and growing market, driven by demographic trends and government initiatives to expand access to healthcare. By offering competitive plans and focusing on quality of care, Elevance Health can attract more members and increase its revenue. This includes partnering with states to manage Medicaid populations and expanding its Medicare Advantage offerings.
• Growth opportunity 3: Strategic Acquisitions and Partnerships: Elevance Health can pursue strategic acquisitions and partnerships to expand its service offerings and geographic reach. This includes acquiring companies with expertise in specialized areas such as behavioral health, pharmacy benefits management, and data analytics. By integrating these capabilities, Elevance Health can offer a more comprehensive suite of services and improve its competitive position. These partnerships can also help Elevance Health enter new markets and reach new customer segments.
• Growth opportunity 4: Enhancing Data Analytics Capabilities: Elevance Health can enhance its data analytics capabilities to improve care management, personalize member experiences, and reduce healthcare costs. By leveraging data analytics, Elevance Health can identify high-risk members, predict healthcare needs, and develop targeted interventions. This includes using data to optimize care pathways, improve medication adherence, and prevent hospital readmissions. The insights gained from data analytics can also inform product development and pricing strategies.
• Growth opportunity 5: Expanding Value-Based Care Arrangements: Elevance Health can expand its value-based care arrangements with providers, aligning incentives to improve quality and reduce costs. Value-based care models reward providers for delivering better outcomes and lower costs, rather than simply providing more services. By partnering with providers in these arrangements, Elevance Health can improve care coordination, reduce unnecessary utilization, and enhance the overall value of healthcare. This includes shared savings programs and bundled payment arrangements.

What Are ELV's Competitive Advantages?

• Scale: Serves approximately 118 million people, providing significant economies of scale.
• Brand Recognition: Well-established brand with a long history in the health insurance industry.
• Network Effects: Large network of providers, offering members access to a wide range of healthcare services.
• Regulatory Expertise: Deep understanding of healthcare regulations and compliance requirements.

What Does ELV Do?

Elevance Health Inc., formerly known as Anthem, Inc., was founded in 1944 and rebranded in June 2022 to reflect its broader focus on health beyond traditional insurance. Headquartered in Indianapolis, Indiana, the company operates as a health benefits provider, offering a wide array of services including medical, digital, pharmacy, behavioral, clinical, and care solutions. Elevance Health supports consumers, families, and communities by connecting them to the necessary care, support, and resources to lead healthier lives. The company serves approximately 118 million people through its various health plans and related offerings. Elevance Health's evolution from a traditional health insurer to a comprehensive health solutions provider underscores its commitment to addressing the holistic health needs of its members. Its offerings include employer-sponsored plans, individual plans, and government-sponsored programs like Medicare and Medicaid. Elevance Health competes with other major players in the health insurance and managed care industry, leveraging its scale and diverse service offerings to maintain a competitive edge.

What Products and Services Does ELV Offer?

• Provides medical benefits plans to individuals, families, and employer groups.
• Offers digital health solutions to improve access to care and enhance patient engagement.
• Manages pharmacy benefits to ensure cost-effective and appropriate medication use.
• Provides behavioral health services to address mental health and substance use disorders.
• Offers clinical and care solutions to improve health outcomes and reduce healthcare costs.
• Connects members to the care, support, and resources they need to lead healthier lives.
• Administers government-sponsored healthcare programs, including Medicare and Medicaid.

How Does ELV Make Money?

• Generates revenue through premiums paid by members for health insurance coverage.
• Earns fees for managing pharmacy benefits and providing other healthcare services.
• Manages healthcare costs through negotiated rates with providers and utilization management programs.
• Invests in technology and innovation to improve efficiency and enhance member experience.

What Industry Does ELV Operate In?

Elevance Health operates within the dynamic and highly regulated healthcare industry. The market is characterized by increasing demand for comprehensive health solutions, driven by an aging population and rising healthcare costs. The industry is also undergoing significant digital transformation, with companies investing in telehealth, data analytics, and personalized medicine. Elevance Health competes with other major health insurers and managed care organizations. The company's focus on integrated care models and digital health positions it to capitalize on these trends and maintain a competitive edge in the evolving healthcare landscape.

Who Are ELV's Key Customers?

• Individuals and families seeking health insurance coverage.
• Employers offering health benefits to their employees.
• Government agencies administering Medicare and Medicaid programs.
• Healthcare providers participating in Elevance Health's network.

Elevance Health Inc. Financial Trajectory

Elevance Health Inc. (ELV) reported $50.47B in revenue for Q2 FY2026, reflecting 0.6% growth compared to the prior quarter. The company recorded net income of $1.46B, with diluted EPS of $6.71. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this large-cap Healthcare company. Across the four most recent quarters, ELV averaged $5.61 in diluted EPS.

Company Profile

Elevance Health Inc. operates in the Medical - Healthcare Plans industry within the Healthcare sector. It is headquartered in Indianapolis, US. The company is led by CEO Gail Koziara Boudreaux. ELV has traded publicly since 2001.

How Elevance Health Inc. Is Valued

Elevance Health Inc. carries a market capitalization of $90.3B, placing it in the large-cap category. Analyst price targets span from $391.00 to $498.00, with a consensus of $444.06. At the current price of $416.54, that implies approximately 7% upside potential. Relative to its peer group, ELV's quantitative score of 86/100 is roughly in line with the peer average of 76/100.

Return on equity for Elevance Health Inc. stands at 12.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.2%, showing how much profit it generates from its asset base. ELV trades at a trailing price-to-earnings ratio of 18.51, below the Healthcare sector average of ~21.50x. Its free cash flow yield is 7.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.48 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 6.1%, the inverse of the P/E and a quick read on earnings relative to price.

Elevance Health Inc.'s Piotroski F-Score is 8/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 3.17 places it in the safe zone, indicating low near-term bankruptcy risk.

Elevance Health Inc. has beaten Wall Street's EPS estimate in 6 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 7.2% above estimates on average.

Over the past six months, Elevance Health Inc. insiders filed 23 SEC Form 4 transactions — 8 sales and 15 purchases. On net that is roughly 7K shares acquired (about $339K) — insiders putting money in tends to read as conviction.

ELV Financials

Next earnings report: Oct 20, 2026

ELV earnings history & estimates →

ELV Latest News

ELV Analyst Consensus

ELV MoonshotScore

Latest Elevance Health Inc. Analysis

What Investors Ask About Elevance Health Inc. (ELV) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources